Korean steel giant signs R&D agreement with Israeli gov't

POSCO, world's 2nd largest steel producer, is 19th foreign corporation and first company from East Asia to join gov't sponsored R&D program.

October 17, 2010 21:51
2 minute read.
Posco steel furnace facility in Korea

311_Posco steel furnace. (photo credit: Posco company website)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Pohang Iron and Steel Company (POSCO), the world’s second-largest steelmaker by market value, has agreed to participate in a joint Israei- Korean industrial R&D program.

Dr. Eli Opper, the chief scientist at the Industry, Trade and Labor Ministry, on Sunday signed a R&D cooperation agreement with POSCO CEO Chang Jeon-Yong that will facilitate the company’s investment in projects in Israel.

IBM’s IT knowledge being used to conserve water
Google purchases Israeli startup Quiksee
IBM buys local data start-up

POSCO is the first East Asian company to participate in a joint R&D agreement under the auspices of the ministry’s Industrial Cooperation Authority. Eighteen other foreign corporations already participate in ICAadministered R&D programs, including Abbott Laboratories, Intel, Oracle, IBM, General Electric, Microsoft, Deutsche Telecom, Merck & Co. and Hewlett-Packard.

POSCO was founded in 1968 as part of a government-private sector initiative by the South Korean government to build a domestic steel industry to supply finished steel to the country’s developing shipping and automotive industries. The company reported $33 billion in global sales in the last fiscal year.

Under the new agreement, the Office of the Chief Scientist will help the company locate Israeli technologies that meet its needs, and provide financial support to fund the R&D required to complete development and commercialization of the technological know-how.

The chief scientist under the authority of the ICA may also provide financial grants equal to up to 50 percent of the total approved corporate R&D expenditures as well as lend research equipment, and provide technical and regulatory advice and marketing assistance.

According to the Office of the Chief Scientist, the goal of the ongoing R&D cooperation program is to encourage increased foreign corporate investment to benefit Israeli society as well as open overseas markets for Israel-designed products. A financial return on the government’s investment is also possible in the event of a successfully commercialized research breakthrough.

“When a government-assisted R&D project results in a commercially successful product, the company is obligated to pay royalties, which will be used to fund future grants to encourage and support other industrial R&D programs. In general, royalty payments are 3%-3.5% of the total annual revenues derived from the sales of a developed product which R&D was supported by OCS grants,” according to the Office of the Chief Scientist’s website.

POSCO participation in an R&D agreement was greatly encouraged by the Korea-Israel Industrial R&D Foundation, which was created by the two countries’ governments in 2001. The foundation has taken a lead role in developing and deepening ties between Israeli and Korean scientists, government officials and business leaders.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings